Gewinn & Umsatz News zur GENUS Aktie

>GENUS Performance

1 Woche: 0%

1 Monat: -3,3%

3 Monate: +4,5%

6 Monate: +29,6%

1 Jahr: +24,1%

laufendes Jahr: +23,4%

>GENUS Aktie

Name:

GENUS PLC LS-,1

Land:

Großbritannien

Sektor:

Gesundheit

ISIN/ Wkn:

GB0002074580 / 762548

Symbol/ Ticker:

GBE (Frankfurt)

Kürzel:

FRA:GBE, ETR:GBE, GBE:GR

Index:

Webseite:

https://www.genusplc.com/

Marktkapitalisierung:

1530 Mio. EUR

Umsatz:

581.47 Mio. EUR

EBITDA:

64.93 Mio. EUR

Gewinn je Aktie:

-0.061 EUR

Schulden:

257.66 Mio. EUR

Liquide Mittel:

41.04 Mio. EUR

Umsatz-/ Gewinnwachstum:

0.8% / -88.1%

KGV/ KGV lG:

33.92 / 24.21

KUV/ KBV/ PEG:

1.95 / 2.51 / -

Gewinnm./ Eigenkapitalr.:

-0.6% / -1.17%

Dividende je Aktie:

0.384 EUR

Dividendenrendite/ -schätzung:

1.7% / 1.65%

Div. Historie:

06.03.25 - 0.12307€
07.11.24 - 0.26056€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

GENUS

Letzte Datenerhebung:

05.07.25

>GENUS Eigentümer

Aktien: 65.69 Mio. St.

f.h. Aktien: 60.44 Mio. St.

Insider Eigner: 0.79%

Instit. Eigner: 88.05%

Leerverk. Aktien: -

>GENUS Peer Group

ANGLE PLC

APTAMER

CONVATEC

CREO MEDICAL

EMV CAPITAL

FUTURA MEDICAL

OXFORD NANOPORE

PURETECH HEALTH

SCANCELL

SHIELD THERAPEUTICS

>GENUS Chart & Kurs - Stuttgart

>GENUS Gewinn & Umsatz News

27.02.25 - 10:24	Genus HY Pre-Tax Profit Down; Declares Unchanged Interim Dividend Of 10.3p/shr (AFX)
	LONDON (dpa-AFX) - Genus plc (GNS.L) reported that its profit before tax for the six months ended 31 December 2024 dropped to 3.3 million pounds from last year's 14.3 million pounds. The latest pe......

15.01.25 - 09:42	Genus Sees H1 Adj. Profit Before Tax Ahead Of Expectations (AFX)
	LONDON (dpa-AFX) - Genus Plc (GNS.L), a biotechnology firm focused on animal genetics, said on Wednesday that it has recorded a strong performance for the first half and expects its earnings ahead......

20.11.24 - 09:25	Genus Plc Expects FY25 Group Adj Profit Before Tax To Be In-line With Market View (AFX)
	LONDON (dpa-AFX) - Global animal genetics company Genus (GNS.L), on Tuesday, issued a trading update for the four months ending 31 October 2024 and said the Board expects Group adjusted profit bef......

05.09.24 - 17:19	Genus FY24 Profit Down (AFX)
	LONDON (dpa-AFX) - Genus (GNS.L) Thursday reported results for the full year 2024, with profit decreasing from a year ago as revenues dropped 3 percentProfit for the year 2.4 million pounds or 11.......

05.09.24 - 09:07	Genus Preliminary Annual Pre-tax Profit Plunges, Revenue Drops (AFX)
	LONDON (dpa-AFX) - Genus Plc (GNS.L), a biotechnology company, on Wednesday reported a steep decline in preliminary pre-tax income for the full year, amidst a fall in revenue. This fall in pre-tax......

17.07.24 - 08:42	Genus Expects FY24 Adj. Profit Before Tax In Actual Currency In Line With Market View (AFX)
	BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Genus (GNS.L) issued an unaudited trading update for fiscal year ended 30 June 2024. Management expects fiscal 2024 adjusted profit before tax in actual curren......

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Männer sind wie Luft, zwar versaut, aber unentbehrlich. - Michelle Pfeiffer

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram